Israel Makov - Chairman

Mr. Israel Makov is the former President & CEO of Teva Pharmaceutical Industries Ltd. He joined Teva in 1995 and led the company's global expansion, managing 12 acquisitions, two of which were the largest M&A deals in Israeli history at the time.

Currently Mr Makov is Chairman of BioLight – a company that invests, manages and commercializes biomedical innovations grouped into “clusters” around defined medical conditions and Chairman of Micromedic Technologies Ltd. - a cluster of companies engaged in cancer diagnostics.

Mr Makov is the former Chairman of Given Imaging—the developer and world’s leading provider of capsule endoscopy and Netafim—the pioneer and global leader in smart irrigation solutions.

Mr Makov is a member of the Board of Directors of the Israel National Nanotechnology Initiative, an initiative he also helped found. He is a member of the International Board of the Weizmann Institute of Science, on the Board of Governors of the Technion – Israel Institute of Technology and President of the Friends of Schneider Children’s Medical Center of Israel. Mr. Makov is also Chairman of the Friends of Gesher Theatre, one of Israel’s leading theaters.

Mr Makov holds a B.Sc. in Agriculture and M.Sc. in Economics from the Hebrew University, Jerusalem.

Dilip Shanghvi - Managing Director

Mr. Dilip Shanghvi is the founder of Sun Pharmaceutical Industries Ltd. and has extensive industrial experience in the pharmaceutical industry. A first generation entrepreneur, Mr. Shanghvi has won numerous awards and recognitions, including Forbes’s Entrepreneur of the Year Award (2014), Economic Times’ Business Leader of the Year (2014), CNN IBN’s Indian of the Year (Business) (2011), Business India's Businessman of the Year (2011) and Ernst and Young's World Entrepreneur of the Year (2011). He has also been awarded the Economic Times' Entrepreneur of the Year (2008), Business Standard’s CEO of the Year (2008) and CNBC TV 18's First Generation Entrepreneur of the Year (2007).

Mr. Shanghvi is also Chairman and Managing Director of Sun Pharma Advanced Research Company Ltd., and Chairman of the Shantilal Shanghvi Foundation. He holds a B.Com degree from the University of Calcutta.

Sudhir V. Valia - Executive Director

Mr. Sudhir V. Valia is a Member of the Institute of Chartered Accountants of India and carries more than three decades of experience in taxation and finance. He has been a director of Sun Pharma since the inception of the company and is also on the board of Taro Pharmaceuticals Ltd.

Mr. Valia has won CNBC TV18's CFO of the Year award in the Pharmaceutical and Healthcare Sectors for two consecutive years (2011 and 2012). He has also been awarded the Adivasi Sevak Puraskar (2008-09) by the Government of Maharashtra for his contribution towards the welfare of tribals, particularly in the field of education in his capacity as Director of the Shantilal Shanghvi Foundation./p>

Sailesh T. Desai - Executive Director

Mr. Sailesh T. Desai has more than 28 years of industrial experience, 18 of which have been in the pharmaceutical industry. Mr. Desai has had comprehensive corporate affairs experience, being involved in the turnaround at Milmet prior to Sun Pharma’s acquisition as well as in the early stages of the company's growth. He holds a BSc degree from the University of Calcutta.

Vivek Chaand Sehgal - Non-Executive Independent Director

Mr. V. C. Sehgal is the Chairman of Samvardhana Motherson Group (SMG). He established Motherson in 1975 with an approximate equity of USD 17 and started a cable and wire manufacturing unit in 1977. Today SMG is a USD 9.1 billion (approx.) Group present in 37 countries with over 230 facilities across the globe. Motherson Sumi Systems Limited (MSSL), the flagship company of the Group, is now one of the largest auto ancillary companies in India.

The Group has a diversified product range covering wiring harnesses, rear view mirrors, integrated plastic modules, lighting systems and a wide range of modules and components. The Group today is one of the leading suppliers of rearview mirrors globally & the leading supplier of polymer modules in Europe along with market leadership positions in most of the other product verticals in India. Under the leadership of Mr. Sehgal, SMG has evolved as a leading full system solutions provider to the global automotive industry

He is a visionary who has the ability of sighting opportunities for the benefit of the Group whether it be in the form of joint ventures or acquisitions. Today the Group has 24 JV partners for its various product ranges and has 19 successful acquisition to its credit.

Mr. Sehgal was adjudged Man of the Year 2010 by Auto Car Professional Magazine. He received Ernst & Young Entrepreneur of the Year Award for manufacturing in 2012. He has been adjudged the Best CEO, 2013 for Auto Ancillaries by Business Today Magazine in India. He was adjudged as the "CEO of the Year 2015" by Business Standard. Under his guidance the flagship company of the group has been adjudged as the "Company of the Year 2014" by Business Standard and feature in Forbs Fab 50 Asia for 4 years in a row. He also received the Best CEO award in 2016 All Asia Executive Team Rankings for autos and auto parts sector by Institutional Investor Magazine. Recently Mr. Sehgal has been declared EY Entrepreneur of the Year 2016.

Keki M. Mistry - Non-Executive Independent Director

Mr. Keki Mistry is Vice Chairman and CEO of the Housing Development Finance Corporation Ltd., one of India’s leading housing finance providers. He has been actively involved in setting up several HDFC group companies including HDFC Bank. Mr. Mistry is also Non-Executive Chairman of Gruh Finance Ltd.. He has been deputed on consultancy assignments for the Commonwealth Development Corporation (CDC) in Thailand, Mauritius and the Caribbean Islands. He has also worked as a consultant for the Mauritius Housing Company and Asian Development Bank.

Some of his recent recognitions include the CFO India Hall of Fame by the CFO Magazine in 2012, CA Business Achiever of the Year award in the Financial Sector by the Institute of Chartered Accountants of India (ICAI) in 2011, Best CFO in the Financial Services category by the ICAI in 2008, Best Performing CFO in the financial services sector for three consecutive years (2006, 2007, 2008) as well as CFO of the Year in 2008 by CNBC TV18 and Best Investor Relations Officer in the Corporate Governance poll by Asiamoney in 2008. Mr. Mistry holds a BCom degree in Advanced Accountancy and Auditing from the University of Mumbai and is a chartered accountant. He is a Fellow of the Institute of Chartered Accountants of India and is a Member of the Michigan Association of Certified Public Accountants.

Ashwin Dani - Non-Executive Independent Director

Mr. Ashwin Dani holds the position of non-executive Vice Chairman of Asian Paints Limited. Earlier, he was Vice Chairman and Managing Director of Asian Paints from December 1998 to March 2009.

He is also a member of the Board at ACC Limited.

He was the Vice President of the Federation of Indian Chambers of Commerce and Industry (FICCI) during 2009-10.

He started his career in 1967 as a developmental chemist with Inmont Corp (now BASF), Detroit, USA, a major supplier of automotive OEM and refinishes. He joined Asian Paints in 1968 as Senior Executive and moved through successive senior positions such as Director-R&D, Works Director, and Whole-time Director & Vice Chairman.

Mr. Dani is the past president of the Indian Paint Association (IPA) and has received a number of awards for his contribution to the paint industry. He has been a member of the Central Board of Trustees-Employees Provident Fund of the Government of India and also the President of the Board of Governors of the UDCT Alumni Association, Mumbai. Currently, he is a member of the Board of the Management of Institute of Chemical Technology (formerly UDCT), Mumbai.

Mr. Dani was born on October 24, 1942, in Kapadwanj, Gujarat. He completed his BSc (Hons) from the Institute of Sciences, University of Bombay, and his BSc (Tech) (Paints, Pigments and Varnishes) from UDCT, University of Bombay. He holds a Master’s degree in Polymer Science from the University of Akron, Ohio, USA and a Diploma in Colour Science from Rensellaer Polytechnic, Troy, New York. He is an ex-managing trustee of the “Light of Yoga”, a trust created by the world famous yogacharya, B.K.S. Iyengar and his disciples.

S. Mohanchand Dadha - Non-Executive Independent Director

Mr. S. Mohanchand Dadha is an entrepreneur with more than five decades of experience in the pharmaceutical industry in India. His family business, M/s Dadha & Co., established in 1914, has the distinction of being one of the oldest pharmaceutical chemists in the country. Mr. Dadha was the Founder and Managing Director of the erstwhile Tamilnadu Dadha Pharmaceuticals Limited. He is also a trustee for many charitable and religious trusts. He has been a member of two Tamil Nadu Government-constituted committees, namely, the Drug Advisory Committee and the Committee for the Development of Drug Industries in Tamil Nadu. Presently, he is also a Director a Sun Pharma Advanced Research Company Limited, Wardex Pharmaceuticals Limited and Dadha Pharma Private Limited. He is Chairman of the Audit Committee and the Remuneration Committee of Sun Pharma Advanced Research Company Limited.

Rekha Sethi - Non-Executive Independent Director

Ms. Rekha Sethi is the Director General of the All India Management Association (AIMA), the apex body for management in India. She took charge of AIMA in June 2008. She is a member of the Indo-Netherlands Joint Working Group on Corporate Governance and Corporate Social Responsibility set up by the Ministry of Corporate Affairs, Government of India. She is also a member of the Advisory Board of the Switzerland based St Gallen Foundation think tank, Leaders of Tomorrow – Knowledge Pool. Prior to joining AIMA, Ms. Sethi had worked with the Confederation of Indian Industry (CII) for over 17 years.

Ms. Sethi graduated in English Literature from St Stephen’s College, Delhi, and has a post-graduate diploma in Advertising and Marketing.

Kalyanasundaram Subramanian - Executive Non-Independent Director

Mr. Kalyanasundaram Subramanian ('Kal'), (born in February, 1954) joined Sun Pharmaceutical Industries Limited ('Sun') in January 2010 after 22 years with GSK.

Kal is a Chemistry graduate and a Chartered Accountant from India with 37 years of experience. He has over three decades of experience in the pharmaceutical industry.

Mr. Kal's career in the pharma industry began when he joined Burroughs Wellcome, in New Zealand as Commercial Advisor in 1988. In his long association with Burroughs Wellcome (which was acquired by Glaxo to become GlaxoWellcome and finally GlaxoSmithKline) he has held various leadership positions including Vice President, Head of Classic Brands Business of Emerging Markets; Area Director South Asia & Managing Director, GSK India; Managing Director – GlaxoWellcome, Singapore (Singapore, Indochina & Myanmar) & Commercial Director - Burroughs Wellcome, New Zealand.

In 2010, Kal joined Sun as the CEO and Director-India and Emerging Markets. He was instrumental in Merck (MSD) and Sun collaboration and spearheaded opening of Sun operations in few important markets such as Japan, MENA.

In 2012, Kal moved to Taro Pharmaceutical Industries Ltd. ('Taro'), USA, a subsidiary of Sun, to assume responsibility of Taro's operations in North America.

In January 2017, Kal moved back to India to manage India and EM regions of Sun and has also been appointed as the CEO & whole-time Director of Sun Pharma Laboratories Limited, a wholly-owned subsidiary of Sun.